Multi‑omics analysis identifies repurposing bortezomib in the treatment of kidney-, nervous system-, and hematological cancers
Favorite
Share
More Options
Fullscreen
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
